Benzinga's Top Initiations
Analysts at Credit Suisse initiated coverage on shares of PTC Therapeutics (NASDAQ: PTCT) with an “outperform” rating. The target price for PTC Therapeutics is set to $24. PTC Therapeutics' shares closed at $16.94 on Friday.
Bank of America initiated coverage on shares of Hannon Armstrong Sustainable Infrastructure Capital (NYSE: HASI) with a “neutral” rating. The target price for Hannon Armstrong Sustainable Infrastructure Capital is set to $12.75. Hannon Armstrong Sustainable Infrastructure Capital's shares closed at $12.26 on Friday.
JP Morgan initiated coverage on shares of bluebird bio (NASDAQ: BLUE) with an “overweight” rating. The target price for bluebird bio is set to $44. bluebird bio's stock closed at $30.65 on Friday.
Analysts at Sterne Agee initiated coverage on shares of Genesco (NYSE: GCO) with a “neutral” rating. Genesco's shares closed at $74.41 on Friday.
Latest Ratings for PTCT
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2021 | Citigroup | Upgrades | Neutral | Buy |
Dec 2020 | Raymond James | Maintains | Outperform | |
Nov 2020 | RBC Capital | Downgrades | Sector Perform | Underperform |
View More Analyst Ratings for PTCT
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings